Oxygenta Pharmaceutical Limited (BOM:524636)

India flag India · Delayed Price · Currency is INR
49.86
-0.74 (-1.46%)
At close: Mar 9, 2026
-34.70%
Market Cap 1.84B
Revenue (ttm) 1.13B
Net Income (ttm) -174.51M
Shares Out 36.98M
EPS (ttm) -4.74
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,688
Average Volume 32,607
Open 51.61
Previous Close 50.60
Day's Range 49.50 - 52.26
52-Week Range 46.00 - 133.50
Beta 0.44
RSI 41.11
Earnings Date May 30, 2026

About Oxygenta Pharmaceutical

Oxygenta Pharmaceutical Limited manufactures and sells pharmaceutical, medical, and veterinary preparations in India. It offers active pharmaceuticals ingredients and commercial intermediates. The company was formerly known as S.S. Organics Limited and changed its name to Oxygenta Pharmaceutical Limited in February 2022. Oxygenta Pharmaceutical Limited was incorporated in 1990 and is based in Hyderabad, India. [Read more]

Industry Pharmaceutical Preparations
Founded 1990
Employees 175
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524636
Full Company Profile

Financial Performance

In fiscal year 2025, Oxygenta Pharmaceutical's revenue was 1.09 billion, an increase of 175.71% compared to the previous year's 396.42 million. Losses were -96.83 million, 178.3% more than in 2024.

Financial Statements

News

There is no news available yet.